Wells Fargo & Company Issues Positive Forecast for Celldex Therapeutics (NASDAQ:CLDX) Stock PriceMarket Beat·20 hours agoCLDX+5.42%UBS-0.44%
Celldex Therapeutics (CLDX) Stock May Trade At A Premium After A 59% RunSimplywall·Jul 22 at 04:12 PMCLDX+5.42%
Wells Fargo & Company Issues Pessimistic Forecast for Celldex Therapeutics (NASDAQ:CLDX) Stock PriceMarket Beat·Jul 22 at 02:18 PMCLDX+5.42%WFC-3.45%
Cantor Fitzgerald Issues Pessimistic Forecast for Celldex Therapeutics (NASDAQ:CLDX) Stock PriceMarket Beat·Jul 22 at 08:12 AMCLDX+5.42%
Celldex Treatment Fails To Relieve Chronic Itch, Abandons Prurigo Nodularis Studybenzinga_article·Jul 22 at 06:29 AMCLDX+5.42%
Celldex ends Phase 2 barzolvolimab trial in prurigo nodularis after missing endpointPUBT·Jul 21 at 03:01 PMCLDX+5.42%
